open access

Vol 14, No 6 (2018)
Review paper
Published online: 2019-03-15
Get Citation

Perioperative management of soft tissue sarcomas

Katarzyna Kozak, Mateusz Spałek
DOI: 10.5603/OCP.2018.0044
·
Oncol Clin Pract 2018;14(6):302-306.

open access

Vol 14, No 6 (2018)
REVIEW ARTICLES
Published online: 2019-03-15

Abstract

Surgery is the standard treatment of all patients with an adult type, localized soft tissue sarcoma. The wide excision is followed by radiation therapy as the standard treatment of high-grade (G2–3), deep, > 5 cm lesions. The goal of (neo)adjuvant radiation therapy is to improve local control, avoid amputation and preserve tissue by limiting the extent of resection. There is no consensus on the current role of adjuvant chemotherapy in localized soft tissue sarcoma. Given the conflicting results of trials and meta-analyses, neoadjuvant chemotherapy can be proposed as an option to the high-risk individual patient.

Abstract

Surgery is the standard treatment of all patients with an adult type, localized soft tissue sarcoma. The wide excision is followed by radiation therapy as the standard treatment of high-grade (G2–3), deep, > 5 cm lesions. The goal of (neo)adjuvant radiation therapy is to improve local control, avoid amputation and preserve tissue by limiting the extent of resection. There is no consensus on the current role of adjuvant chemotherapy in localized soft tissue sarcoma. Given the conflicting results of trials and meta-analyses, neoadjuvant chemotherapy can be proposed as an option to the high-risk individual patient.
Get Citation

Keywords

soft tissue sarcoma; adjuvant radiotherapy; adjuvant chemotherapy

About this article
Title

Perioperative management of soft tissue sarcomas

Journal

Oncology in Clinical Practice

Issue

Vol 14, No 6 (2018)

Article type

Review paper

Pages

302-306

Published online

2019-03-15

DOI

10.5603/OCP.2018.0044

Bibliographic record

Oncol Clin Pract 2018;14(6):302-306.

Keywords

soft tissue sarcoma
adjuvant radiotherapy
adjuvant chemotherapy

Authors

Katarzyna Kozak
Mateusz Spałek

References (20)
  1. Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982; 196(3): 305–315.
  2. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998; 16(1): 197–203.
  3. Rutkowski P, Ługowska I, Fijuth J, et al. Soft tissue sarcomas in adults. Oncol Clin Pract 2017; 13: 181–201. DOI: 10 5603/OCP. ; 2017: 0025.
  4. O'Sullivan B, Griffin AM, Dickie CI, et al. Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma. Cancer. 2013; 119(10): 1878–1884.
  5. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002; 359(9325): 2235–2241.
  6. Haas RLM, Miah AB, LePechoux C, et al. Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies. Radiother Oncol. 2016; 119(1): 14–21.
  7. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997; 350(9092): 1647–1654.
  8. Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008; 113(3): 573–581.
  9. Woll PJ, Reichardt P, Le Cesne A, et al. EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012; 13(10): 1045–1054.
  10. Bramwell V, Rouesse J, Steward W, et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1994; 12(6): 1137–1149.
  11. Le Cesne A, Ouali M, Leahy MG, et al. Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials. Ann Oncol. 2014; 25(12): 2425–2432.
  12. Gronchi A, Frustaci S, Mercuri M, et al. Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. J Clin Oncol. 2012; 30(8): 850–856.
  13. Gronchi A, Stacchiotti S, Verderio P, et al. Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. Ann Oncol. 2016; 27(12): 2283–2288.
  14. Stacchiotti S, Verderio P, Messina A, et al. Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer. 2012; 118(23): 5857–5866.
  15. Deroose JP, Eggermont AMM, van Geel AN, et al. Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas. J Clin Oncol. 2011; 29(30): 4036–4044.
  16. Rothermundt C, Fischer GF, Bauer S, et al. Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey. Oncologist. 2018; 23(4): 461–467.
  17. Gronchi A, Ferrari S, Quagliuolo V, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017; 18(6): 812–822.
  18. Palassini E, Ferrari S, Verderio P, et al. Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide. J Clin Oncol. 2015; 33(31): 3628–3634.
  19. Casali PG, Abecassis N, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29 (Suppl 4): iv51-iv67. doi: 10.1093/annonc/mdy096.
  20. Rutkowski P, Ługowska I, Fijuth J, et al. Soft tissue sarcomas in adults. Oncol Clin Pract 2017; 13: 181–201. DOI: 10 5603/OCP. ; 2017: 0025.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl